LeadIQ logo
Learn more at LeadIQ.com

Insights

ADC Pipeline Expansion Mersana Therapeutics is actively developing novel antibody-drug conjugates (ADCs) targeting various cancers, such as B7-H4 and HER2, indicating potential sales opportunities in the oncology market.

Recent Technological Adoption The company's utilization of modern tech stack components like Hyperion and PWA showcases a commitment to innovation, presenting opportunities for tech-oriented partnerships or solutions within the biopharma sector.

Positive Financial Outlook With a recent bullish quarterly report and $100M in funding, Mersana Therapeutics demonstrates financial stability and growth potential, making them an attractive prospect for investment or collaboration.

Leadership Transition Following a change in leadership with Martin Huber appointed as President and CEO, exploring new business relationships under fresh leadership could lead to mutually beneficial sales or strategic partnerships.

Strategic Milestone Payments Receiving $6 million in milestone payments signifies industry recognition and progress, suggesting opportunities for collaborations, joint ventures, or product advancements within the biotech landscape.

Mersana Therapeutics Tech Stack

Mersana Therapeutics uses 8 technology products and services including Hyperion, Google Font API, Exhibit, and more. Explore Mersana Therapeutics's tech stack below.

  • Hyperion
    Corporate Performance Management
  • Google Font API
    Font Scripts
  • Exhibit
    Javascript Graphics
  • Modernizr
    Javascript Libraries
  • PWA
    Miscellaneous
  • FedEx
    Transportation And Fleet Management
  • Acquia Cloud Site Factory
    Web Hosting
  • Twitter
    Widgets

Media & News

Mersana Therapeutics's Email Address Formats

Mersana Therapeutics uses at least 1 format(s):
Mersana Therapeutics Email FormatsExamplePercentage
flast@mersana.comJDoe@mersana.com
83%
first.last@mersana.comJohn.Doe@mersana.com
9%
last@mersana.comDoe@mersana.com
8%
first@mersana.comJohn@mersana.com
0%

Frequently Asked Questions

Where is Mersana Therapeutics's headquarters located?

Minus sign iconPlus sign iconMersana Therapeutics's main headquarters is located at 840 Memorial Drive Cambridge, MA 02139 US. The company has employees across 2 continents, including North AmericaAsia.

What is Mersana Therapeutics's phone number?

Minus sign iconPlus sign icon You can contact Mersana Therapeutics's main corporate office by phone at +1-212-362-1200. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Mersana Therapeutics's stock symbol?

Minus sign iconPlus sign iconMersana Therapeutics is a publicly traded company; the company's stock symbol is MRSN.

What is Mersana Therapeutics's official website and social media links?

Minus sign iconPlus sign iconMersana Therapeutics's official website is mersana.com and has social profiles on LinkedIn.

How much revenue does Mersana Therapeutics generate?

Minus sign iconPlus sign icon As of May 2024, Mersana Therapeutics's annual revenue reached $35M.

What is Mersana Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconMersana Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Mersana Therapeutics have currently?

Minus sign iconPlus sign iconAs of May 2024, Mersana Therapeutics has approximately 172 employees across 2 continents, including North AmericaAsia. Key team members include Chief Operating Officer & Chief Financial Officer: B. D.Chief Financial Officer: B. D.Chief Manufacturing Officer: T. M.. Explore Mersana Therapeutics's employee directory with LeadIQ.

What industry does Mersana Therapeutics belong to?

Minus sign iconPlus sign iconMersana Therapeutics operates in the Biotechnology Research industry.

What technology does Mersana Therapeutics use?

Minus sign iconPlus sign iconMersana Therapeutics's tech stack includes HyperionGoogle Font APIExhibitModernizrPWAFedExAcquia Cloud Site FactoryTwitter.

What is Mersana Therapeutics's email format?

Minus sign iconPlus sign iconMersana Therapeutics's email format typically follows the pattern of . Find more Mersana Therapeutics email formats with LeadIQ.

How much funding has Mersana Therapeutics raised to date?

Minus sign iconPlus sign icon As of May 2024, Mersana Therapeutics has raised $100M in funding. The last funding round occurred on Jan 01, 2021.

When was Mersana Therapeutics founded?

Minus sign iconPlus sign iconMersana Therapeutics was founded in 2001.
Mersana Therapeutics

Mersana Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

At Mersana, we have a passion for advancing therapies to make a significant impact in the lives of people living with cancer. 

Mersana Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel antibody-drug conjugates (ADCs) and driven by the knowledge that patients are waiting for new treatment options. The company has developed proprietary cytotoxic (Dolasynthen) and immunostimulatory (Immunosynthen) ADC platforms that are generating a pipeline of wholly-owned and partnered product candidates with the potential to treat a range of cancers. Its pipeline includes XMT-1660, a Dolasynthen ADC targeting B7-H4, and XMT-2056, an Immunosynthen ADC targeting a novel epitope of human epidermal growth factor receptor 2 (HER2).

Section iconCompany Overview

Headquarters
840 Memorial Drive Cambridge, MA 02139 US
Phone number
+1-212-362-1200
Website
mersana.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
MRSN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2001
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $100M

    Mersana Therapeutics has raised a total of $100M of funding over 12 rounds. Their latest funding round was raised on Jan 01, 2021.

  • $10M$50M

    Mersana Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $100M

    Mersana Therapeutics has raised a total of $100M of funding over 12 rounds. Their latest funding round was raised on Jan 01, 2021.

  • $10M$50M

    Mersana Therapeutics's revenue is in the range of $10M$50M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.